MASUI
BIIB icon

MIRAE ASSET SECURITIES (USA) INC.’s Biogen BIIB Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,059
Closed -$2.9M – 176
2025
Q2 		$2.9M Buy
23,059
+1,605
+7% +$200K 0.09% 143
2025
Q1 		$2.94M Sell
21,454
-18,650
-47% -$2.67M 0.08% 137
2024
Q4 		$6.13M Buy
+40,104
New +$6.76M 0.18% 90

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s BIIB Position: Q3 2025 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Biogen (BIIB) in Q3 2025, closing a stake of 23,059 shares — an estimated $2.9M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in BIIB in Q4 2024 and held it in 3 quarters. The position peaked at $6.13M in Q4 2024. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 23,059 Biogen shares in Q3 2025, an estimated $2.9M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Biogen in Q4 2024 and held it in 3 quarters.
  • MIRAE ASSET SECURITIES (USA) INC.'s Biogen position peaked at $6.13M in Q4 2024.
  • 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q3 2025, filed 24 Oct 2025.